These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7784540)

  • 1. Fundamentals of drug design from a biophysical viewpoint.
    van Gunsteren WF; King PM; Mark AE
    Q Rev Biophys; 1994 Dec; 27(4):435-81. PubMed ID: 7784540
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure-activity relationships of cannabinoids: a joint CoMFA and pseudoreceptor modelling study.
    Schmetzer S; Greenidge P; Kovar KA; Schulze-Alexandru M; Folkers G
    J Comput Aided Mol Des; 1997 May; 11(3):278-92. PubMed ID: 9263855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand-protein docking and rational drug design.
    Lybrand TP
    Curr Opin Struct Biol; 1995 Apr; 5(2):224-8. PubMed ID: 7648325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational drug design accommodating receptor flexibility: the relaxed complex scheme.
    Lin JH; Perryman AL; Schames JR; McCammon JA
    J Am Chem Soc; 2002 May; 124(20):5632-3. PubMed ID: 12010024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-D and 3-D modeling of imidazoline receptor ligands: insights into pharmacophore.
    Carrieri A; Brasili L; Leonetti F; Pigini M; Giannella M; Bousquet P; Carotti A
    Bioorg Med Chem; 1997 May; 5(5):843-56. PubMed ID: 9208096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermodynamic aspects of hydrophobicity and biological QSAR.
    Kim KH
    J Comput Aided Mol Des; 2001 Apr; 15(4):367-80. PubMed ID: 11349818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer modelling of G protein-coupled receptors: promises and drawbacks.
    Maigret B
    J Pharm Belg; 1997; 52(2):102. PubMed ID: 9193133
    [No Abstract]   [Full Text] [Related]  

  • 8. Predictive models of protein-active sites.
    Walters DE
    Methods Mol Biol; 2000; 143():349-58. PubMed ID: 11084913
    [No Abstract]   [Full Text] [Related]  

  • 9. Biophysical tools for structure-based drug design.
    Wendoloski JJ; Shen J; Oliva MT; Weber PC
    Pharmacol Ther; 1993 Nov; 60(2):169-83. PubMed ID: 8022856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct calculation of the binding free energies of FKBP ligands.
    Fujitani H; Tanida Y; Ito M; Jayachandran G; Snow CD; Shirts MR; Sorin EJ; Pande VS
    J Chem Phys; 2005 Aug; 123(8):084108. PubMed ID: 16164283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor-assisted combinatorial chemistry: thermodynamics and kinetics in drug discovery.
    Cheeseman JD; Corbett AD; Gleason JL; Kazlauskas RJ
    Chemistry; 2005 Mar; 11(6):1708-16. PubMed ID: 15565741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of receptor-bound drug conformations by QSAR using flexible fitting to derive a molecular similarity index.
    Montanari CA; Tute MS; Beezer AE; Mitchell JC
    J Comput Aided Mol Des; 1996 Feb; 10(1):67-73. PubMed ID: 8786416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary sequences of proteinlike copolymers: Levy-flight-type long-range correlations.
    Govorun EN; Ivanov VA; Khokhlov AR; Khalatur PG; Borovinsky AL; Grosberg AY
    Phys Rev E Stat Nonlin Soft Matter Phys; 2001 Oct; 64(4 Pt 1):040903. PubMed ID: 11690003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular electrostatic potential as a factor of drug-receptor recognition.
    Dukhovich FS; Darkhovskii MB
    J Mol Recognit; 2003; 16(4):191-202. PubMed ID: 12898669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolutionary algorithms in computer-aided molecular design.
    Clark DE; Westhead DR
    J Comput Aided Mol Des; 1996 Aug; 10(4):337-58. PubMed ID: 8877705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractional description of free energies of solvation.
    Luque FJ; Barril X; Orozco M
    J Comput Aided Mol Des; 1999 Mar; 13(2):139-52. PubMed ID: 10091120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening.
    Tanrikulu Y; Schneider G
    Nat Rev Drug Discov; 2008 Aug; 7(8):667-77. PubMed ID: 18636071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide folding kinetics from replica exchange molecular dynamics.
    Buchete NV; Hummer G
    Phys Rev E Stat Nonlin Soft Matter Phys; 2008 Mar; 77(3 Pt 1):030902. PubMed ID: 18517321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies in the rational drug design.
    Mavromoustakos T; Durdagi S; Koukoulitsa C; Simcic M; Papadopoulos MG; Hodoscek M; Grdadolnik SG
    Curr Med Chem; 2011; 18(17):2517-30. PubMed ID: 21568895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor-drug association studies in the inhibition of the hematin aggregation process of malaria.
    Portela C; Afonso CM; Pinto MM; Ramos MJ
    FEBS Lett; 2003 Jul; 547(1-3):217-22. PubMed ID: 12860417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.